Key facts
- This page summarizes Shalini Sharp's Form 4 filing for NEUROCRINE BIOSCIENCES INC (NBIX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 21 May 2026, 19:24.
Shalini Sharp - 21 May 2026 Form 4 Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)
- Reporting relationship
- Director
- Issuer ticker
- NBIX
- Reported as of
- 21 May 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 21 May 2026, 19:24:25 UTC
- Prior SEC filing
- 20 Jun 2025
- Next SEC filing
- 29 May 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Darin Lippoldt, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Shalini Sharp filed Form 4 for NEUROCRINE BIOSCIENCES INC (NBIX) on 21 May 2026.
Change
- Previous filing in this sequence was filed on 20 Jun 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001377202
Primary reporting owner
Sharp Shalini
- Relationship
- Director
- Address
- 6027 EDGEWOOD BEND CT., SAN DIEGO
- Signature
- /s/ Darin Lippoldt, Attorney-in-Fact
- Signature date
- 21 May 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NBIX
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +1,659
- Change %
- +68%
- Price
- $0.000000*
- Shares after
- 4,088
- Date
- 21 May 2026
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NBIX
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- Shares
- -1,659
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 21 May 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,659
- Exercise price
- $0.000000
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.
Footnote F2
This RSU award was granted to the Reporting Person on May 21, 2025 and is fully vested.